Clinical scenario
Lennox-Gastaut syndrome is a severe, treatment-resistant epilepsy syndrome. Beyond anti-seizure medication (ASM) therapy, established non-pharmacological interventions play a meaningful role and should be integrated into the treatment plan and discussed with the patient from the outset.
Treatment approach — partial overview
The management of LGS includes specific non-pharmacological modalities used in conjunction with ASM therapy. Among these, a structured dietary intervention is one option whose clinical response can be assessed within a defined timeframe. The full set of interventions, their indications, patient-selection criteria, and sequencing are detailed in the complete protocol.
Response to certain approaches may be evaluable within 3 months